Back to search
Other Haemostasis Disorder
Clinical trial pipeline · Data from ClinicalTrials.gov
See which Other Haemostasis Disorder trials you may qualify forClinical trial pipeline · Data from ClinicalTrials.gov
See which Other Haemostasis Disorder trials you may qualify forBackground: Blood cancers (such as leukemias) can be hard to treat, especially if they have mutations in the TP53 or RAS genes. These mutations can cause the c…
The purpose of this study is to learn about the study medicine called elranatamab.This study aims to compare elranatamab to other medicines for the treatment of…
The purpose of this clinical trial is to (1) learn whether the BCMA-CD3 bispecific antibody elranatamab can provide more benefit to people with multiple myeloma…
This study is a 2-part study with a dose-escalation part and a dose-expansion part. The aim of the dose-escalation part is to determine the maximum tolerated do…
A phase 1/2 dose escalation / dose expansion study of Enzomenib (DSP-5336) in patients with acute leukemia.
This Phase 1/2 study evaluates the safety, feasibility, and preliminary anti-tumor activity of allogeneic donor-derived CAR-NK cells in participants with advanc…
The purpose of this study is to characterize the safety and tolerability of talquetamab when administered in different combination regimens and to identify the…
The purpose of this study is to characterize the safety and tolerability of teclistamab when administered in different combination regimen and to identify the o…